Business Context and Reporting Period
This Form 8-K filing by BIO-RAD LABORATORIES, INC. reports on the results of the Annual Meeting of Stockholders held on April 29, 2019. The report was filed on May 2, 2019, and covers corporate governance matters, specifically the election of directors and the ratification of independent auditors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report regarding stockholder votes and does not contain financial performance data.
Material Changes
No material financial changes or operational updates are disclosed in this filing. The document focuses exclusively on the outcomes of the stockholder vote.
Guidance, Outlook, and Management Commentary
The filing contains no guidance, outlook, or management commentary regarding future financial performance. It details the following corporate actions:
- Election of Directors: All nominated directors were elected by a majority of votes cast in their respective classes of Common Stock.
- Auditor Ratification: The proposal to ratify KPMG LLP as the independent auditors for the fiscal year ending December 31, 2019, was approved.
Important Facts for Investors to Verify
- Confirmation that all six nominated directors (Melinda Litherland, Arnold A. Pinkston, Jeffrey L. Edwards, Gregory K. Hinckley, Alice N. Schwartz, and Norman Schwartz) were successfully elected.
- Verification that KPMG LLP has been ratified as the independent auditor for the 2019 fiscal year.
- Review of the specific vote counts for Class A and Class B stock to assess shareholder sentiment, noting that Class A votes were significantly higher in volume than Class B votes.